Afficher la notice abrégée

dc.contributor.authorWilliams, Gareth R.*
dc.contributor.authorBlagbrough, Ian S.*
dc.date.accessioned2021-02-11T12:20:46Z
dc.date.available2021-02-11T12:20:46Z
dc.date.issued2019*
dc.date.submitted2019-06-26 10:09:00*
dc.identifier33725*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/46161
dc.description.abstractThis book is comprised of important reviews and cutting-edge original research papers concerning electrospun and electrosprayed formulations in drug delivery. Electrospinning and electrospraying have, in recent years, attracted increasing attention in the pharmaceutical sector, with research in the area advancing rapidly. It is now possible to prepare extremely complex systems using multi-fluid processes, and to increase production rates to an industrial scale. Electrospun formulations can be produced under GMP conditions and are in clinical trials. In this volume, we explore a range of topics around electrospinning and electrospraying in controlled drug delivery. Four reviews cover the exciting potential of cyclodextrin-containing fibers and the many potential biomedical applications of electrospun fibers. The use of electrospinning to prepare amorphous systems and improve the dissolution rate and solubility of poorly soluble active ingredients is addressed, and the possibilities of such materials in tissue engineering are comprehensively covered. The six original research papers cover the effect of molecular properties on API release from Eudragit-based electrospun fibers; ferulic acid solid dispersions; electrospun medicines to treat psoriasis; scale up of electrospinning and its use to produce low-dose tablets; transepithelial permeation of drugs released from electrospun fibers, and the possibilities for the synergistic chemophotothermal treatment of cancer.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRM1-950*
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.othertissue engineering*
dc.subject.othercyclodextrin*
dc.subject.otherpermeability*
dc.subject.otherpoly (vinylpyrrolidone-co-vinyl acetate)*
dc.subject.othercrystalline*
dc.subject.otherantibacterial*
dc.subject.otherdrug delivery*
dc.subject.otherhomogenization*
dc.subject.othercapsaicin*
dc.subject.othercombination therapy*
dc.subject.otherhigh-shear mixing*
dc.subject.othercyclodextrin-inclusion complexes*
dc.subject.otheramorphous*
dc.subject.otherhigh-speed electrospinning*
dc.subject.otherPMVE/MA*
dc.subject.otheraqueous solubility enhancement*
dc.subject.othersieve analysis*
dc.subject.otherRaman mapping*
dc.subject.otherEudragit*
dc.subject.othernanofibers*
dc.subject.otherpsoriasis*
dc.subject.otherPCL*
dc.subject.otheressential oils*
dc.subject.otherparameters*
dc.subject.otherantibiotics*
dc.subject.otherxanthan gum*
dc.subject.othercarvedilol*
dc.subject.otheramorphous composite*
dc.subject.othercoaxial electrospinning*
dc.subject.otherinsoluble drug*
dc.subject.otherNIR-triggered drug release*
dc.subject.otherfast dissolution*
dc.subject.otherelectrospinning*
dc.subject.otheroral drug delivery*
dc.subject.otherelectrospun nanofibers*
dc.subject.otherpoly-cyclodextrin*
dc.subject.otherTRPV1*
dc.subject.othergallic acid*
dc.subject.othersolid dispersion*
dc.subject.otherphotothermal therapy*
dc.subject.otherdrug release*
dc.subject.otherapplications*
dc.titleElectrospun and Electrosprayed Formulations for Drug Delivery*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03897-913-5*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783038979135*
oapen.relation.isbn9783038979128*
oapen.pages190*
oapen.edition1st*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc-nd/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc-nd/4.0/